Protein biomarkers that can identify Alzheimer's with about 90% accuracy have been discovered. With a simple blood test, even the earliest stages of Alzheimer’s and Mild Cognitive Impairment can be reliably differentiated from controls. Working in collaboration with dementia centers in the US and Europe, our vision is to combine early diagnosis of Alzheimer's with presently available therapies and future disease-modifying therapies.
LATEST NEWS
May 16, 2008 Detecting Alzheimer's Disease
Anna Davison, Technology Review more >
|
Blood Test Takes Step Toward Predicting Alzheimer’s Risk
